ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:ABL • US0028241000
94.28 EUR
+1.01 (+1.08%)
Last: Feb 10, 2026, 05:29 PM
ABL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. ABL has an excellent profitability rating, but there are some minor concerns on its financial health. ABL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year ABL was profitable.
- In the past year ABL had a positive cash flow from operations.
- ABL had positive earnings in each of the past 5 years.
- ABL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of ABL (16.60%) is better than 93.65% of its industry peers.
- ABL's Return On Equity of 27.43% is amongst the best of the industry. ABL outperforms 95.24% of its industry peers.
- The Return On Invested Capital of ABL (8.88%) is better than 73.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 8.88% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ABL has a Profit Margin of 31.88%. This is amongst the best in the industry. ABL outperforms 98.41% of its industry peers.
- In the last couple of years the Profit Margin of ABL has grown nicely.
- ABL's Operating Margin of 18.29% is fine compared to the rest of the industry. ABL outperforms 76.19% of its industry peers.
- In the last couple of years the Operating Margin of ABL has grown nicely.
- Looking at the Gross Margin, with a value of 56.19%, ABL is in line with its industry, outperforming 49.21% of the companies in the same industry.
- ABL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
- ABL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- ABL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 5.28 indicates that ABL is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 5.28, ABL belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
- ABL has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
- ABL's Debt to FCF ratio of 1.87 is fine compared to the rest of the industry. ABL outperforms 79.37% of its industry peers.
- ABL has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
- ABL has a Debt to Equity ratio of 0.23. This is in the better half of the industry: ABL outperforms 68.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.28 |
ROIC/WACC0.92
WACC9.67%
2.3 Liquidity
- ABL has a Current Ratio of 1.70. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of ABL (1.70) is comparable to the rest of the industry.
- A Quick Ratio of 1.24 indicates that ABL should not have too much problems paying its short term obligations.
- ABL has a Quick ratio (1.24) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 10.28% over the past year.
- ABL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
- The Revenue has been growing slightly by 5.67% in the past year.
- The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- The Earnings Per Share is expected to grow by 10.18% on average over the next years. This is quite good.
- ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.15% yearly.
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.18%
Revenue Next Year7%
Revenue Next 2Y7.2%
Revenue Next 3Y7.11%
Revenue Next 5Y7.15%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 21.77 indicates a rather expensive valuation of ABL.
- Based on the Price/Earnings ratio, ABL is valued cheaper than 80.95% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.06. ABL is valued slightly cheaper when compared to this.
- The Price/Forward Earnings ratio is 19.51, which indicates a rather expensive current valuation of ABL.
- 60.32% of the companies in the same industry are more expensive than ABL, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of ABL to the average of the S&P500 Index (27.86), we can say ABL is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.77 | ||
| Fwd PE | 19.51 |
4.2 Price Multiples
- ABL's Enterprise Value to EBITDA ratio is in line with the industry average.
- ABL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ABL is cheaper than 61.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.17 | ||
| EV/EBITDA | 17.73 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.89
PEG (5Y)3.05
EPS Next 2Y10.76%
EPS Next 3Y10.33%
5. Dividend
5.1 Amount
- ABL has a Yearly Dividend Yield of 2.31%. Purely for dividend investing, there may be better candidates out there.
- ABL's Dividend Yield is rather good when compared to the industry average which is at 0.97. ABL pays more dividend than 82.54% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.80, ABL pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.31% |
5.2 History
- On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- ABL pays out 28.93% of its income as dividend. This is a sustainable payout ratio.
- ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
FRA:ABL (2/10/2026, 5:29:50 PM)
94.28
+1.01 (+1.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.33%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap163.94B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts79.43
Price Target115.93 (22.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.31% |
Yearly Dividend1.88
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-6.91%
PT rev (3m)-8.39%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.16%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.88%
Revenue NY rev (3m)-0.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.77 | ||
| Fwd PE | 19.51 | ||
| P/S | 4.44 | ||
| P/FCF | 28.17 | ||
| P/OCF | 21.37 | ||
| P/B | 3.82 | ||
| P/tB | 9.11 | ||
| EV/EBITDA | 17.73 |
EPS(TTM)4.33
EY4.59%
EPS(NY)4.83
Fwd EY5.12%
FCF(TTM)3.35
FCFY3.55%
OCF(TTM)4.41
OCFY4.68%
SpS21.21
BVpS24.65
TBVpS10.35
PEG (NY)1.89
PEG (5Y)3.05
Graham Number49.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 8.88% | ||
| ROICexc | 9.99% | ||
| ROICexgc | 19.14% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.28 |
F-Score8
WACC9.67%
ROIC/WACC0.92
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.18%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.2%
Revenue Next 3Y7.11%
Revenue Next 5Y7.15%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.17%
EBIT Next 3Y13.91%
EBIT Next 5Y14.39%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A
ABBOTT LABORATORIES / ABL.DE FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
What is the profitability of ABL stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for ABL stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 21.77 and the Price/Book (PB) ratio is 3.82.
How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 28.93%.